SP012 Medication adherence in patients with Parkinson's disease treated at a specialized ambulatory

Abstract

Parkinson's disease (PD) is universal and the second most common neurodegenerative disease in the elderly after Alzheimer's disease, with highly prevalent, affecting between 0.5 and 1% of the population aged between 65 and 69 years. Drug treatment is the main way to control the symptoms of PD. The goal of therapy is to increase dopaminergic activity in the basal ganglia and it is known that levodopa is the most commonly prescribed and effective drug for this purpose, promoting an improvement in the quality of life in these patients. Even though that adherence to antiparkinsonian medication is fundamental to achieving this improvement, maximizing the effect of medication and patient response to the drug, only recently it has been studied in patients with Parkinson's disease.